Beaumont RCSI Cancer Centre

Study chosen for oral presentation at BTOG 2025

January 15, 2025 | Blog
Study chosen for oral presentation at BTOG 2025

Congratulations to clinical research fellow David O’Reilly and the research team who have been selected to for an oral presentation at BTOG (British Thoracic Oncology Group) Annual Meeting 2025.

The project titled “Prospective evaluation of clinical benefit and cost of plasma-first next-generation sequencing for the genomic assessment of patients with newly diagnosed advanced non-small cell lung cancer” represents the key work in Lung Cancer research in the cancer centre.

David O'Reilly, thumbnail photo

David O’Reilly, Clinical Research Fellow

#BTOG25

@BTOGorg, @CancerCentreIre